SCHEMBL15065607

SCHEMBL15065607

C(CNCCCN1CCNCC1)CN1CCNCC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 3/20 0.54
HSD17B10 Q99714 1/20 0.48
SIGMAR1 Q99720 2/20 0.46
RAD52 P43351 1/20 0.46
POLB P06746 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
ACE2 Q9BYF1 1/20 0.43
ANPEP P15144 1/20 0.42
ERAP2 Q6P179 1/20 0.42
ALDH1A1 P00352 1/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CHRM2 P08172 1/20 0.40
CHRM4 P08173 1/20 0.40
CHRM5 P08912 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15065509 0.93 CXCR4 (0.55) CXCR4HSD17B10SIGMAR1RAD52POLB
SCHEMBL8306593 0.92 ACE2 (0.57) CXCR4HSD17B10SIGMAR1RAD52POLB
SCHEMBL15065656 0.91 CXCR4 (0.59) CXCR4HSD17B10SIGMAR1RAD52POLB
SCHEMBL15066181 0.91 CXCR4 (0.59) CXCR4HSD17B10SIGMAR1RAD52POLB
SCHEMBL15065371 0.91 CXCR4 (0.59) CXCR4HSD17B10SIGMAR1RAD52POLB
SCHEMBL18024048 0.90 HSD17B10 (0.46) CXCR4HSD17B10SIGMAR1RAD52POLB
SCHEMBL31468943 0.90 CXCR4 (0.46) CXCR4HSD17B10SIGMAR1RAD52POLB
SCHEMBL8306592 0.90 CXCR4 (0.46) CXCR4HSD17B10SIGMAR1RAD52POLB
SCHEMBL31468940 0.90 TLR8 (0.46) CXCR4HSD17B10SIGMAR1RAD52POLB
SCHEMBL8306631 0.90 CXCR4 (0.46) CXCR4HSD17B10SIGMAR1RAD52POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4683507-A1 ENCAPSULATED AGRICULTURAL CHEMICALS DOW GLOBAL TECHNOLOGIES LLC (US) 2026-01-28 EP claimed
WO-2024196625-A1 ENCAPSULATED AGRICULTURAL CHEMICALS DOW GLOBAL TECHNOLOGIES LLC (US) 2024-09-26 WO claimed
US-9688875-B2 Epoxy coating systems using polycyclic polyamines as epoxy hardeners DOW GLOBAL TECHNOLOGIES LLC (US) 2017-06-27 US claimed
EP-2797981-B1 EPOXY COATING SYSTEMS USING POLYCYCLIC POLYAMINES AS EPOXY HARDENERS DOW GLOBAL TECHNOLOGIES LLC (US) 2017-05-24 EP claimed
EP-2797901-B1 FORMATION OF HIGHER MOLECULAR WEIGHT CYCLIC POLYAMINE COMPOUNDS FROM CYCLIC POLYAMINE COMPOUNDS DOW GLOBAL TECHNOLOGIES LLC (US) 2017-05-10 EP claimed
EP-4683507-A1 ENCAPSULATED AGRICULTURAL CHEMICALS DOW GLOBAL TECHNOLOGIES LLC (US) 2026-01-28 EP disclosed
WO-2024196625-A1 ENCAPSULATED AGRICULTURAL CHEMICALS DOW GLOBAL TECHNOLOGIES LLC (US) 2024-09-26 WO disclosed
US-9688875-B2 Epoxy coating systems using polycyclic polyamines as epoxy hardeners DOW GLOBAL TECHNOLOGIES LLC (US) 2017-06-27 US disclosed
EP-2797981-B1 EPOXY COATING SYSTEMS USING POLYCYCLIC POLYAMINES AS EPOXY HARDENERS DOW GLOBAL TECHNOLOGIES LLC (US) 2017-05-24 EP disclosed
EP-2797903-B1 AMINE POLYETHER POLYOLS AND POLYURETHANE FOAM COMPOSITIONS MADE FROM CYCLIC AMINE COMPOUNDS DOW GLOBAL TECHNOLOGIES LLC (US) 2017-05-17 EP disclosed
EP-2797901-B1 FORMATION OF HIGHER MOLECULAR WEIGHT CYCLIC POLYAMINE COMPOUNDS FROM CYCLIC POLYAMINE COMPOUNDS DOW GLOBAL TECHNOLOGIES LLC (US) 2017-05-10 EP disclosed
US-9644066-B2 Cyclic amine compounds, compositions, and polyurethane foams made therefrom DOW GLOBAL TECHNOLOGIES LLC (US) 2017-05-09 US disclosed
US-9611351-B2 Amine polyether polyols and polyurethane foam compositions made from cyclic amine compounds DOW GLOBAL TECHNOLOGIES LLC. (US) 2017-04-04 US disclosed
WO-2016130968-A1 BIARYLTRIAZOLE INHIBITORS OF MACROPHAGE MIGRATION INHIBITORY FACTOR YALE UNIVERSITY (US) 2016-08-18 WO disclosed
US-20150005404-A1 CYCLIC AMINE COMPOUNDS, COMPOSITIONS, AND POLYURETHANE FOAMS MADE THEREFROM DOW GLOBAL TECHNOLOGIES LLC 2015-01-01 US disclosed
US-20140357750-A1 AMINE POLYETHER POLYOLS AND POLYURETHANE FOAM COMPOSITIONS MADE FROM CYCLIC AMINE COMPOUNDS DOW GLOBAL TECHNOLOGIES LLC (US) 2014-12-04 US disclosed
EP-2797902-A2 CYCLIC AMINE COMPOUNDS, COMPOSITIONS, AND POLYURETHANE FOAMS MADE THEREFROM Dow Global Technologies LLC (US) 2014-11-05 EP disclosed
EP-2797903-A1 AMINE POLYETHER POLYOLS AND POLYURETHANE FOAM COMPOSITIONS MADE FROM CYCLIC AMINE COMPOUNDS Dow Global Technologies LLC (US) 2014-11-05 EP disclosed
WO-2013102053-A1 AMINE POLYETHER POLYOLS AND POLYURETHANE FOAM COMPOSITIONS MADE FROM CYCLIC AMINE COMPOUNDS DOW GLOBAL TECHNOLOGIES LLC (US) 2013-07-04 WO disclosed
WO-2013102097-A2 CYCLIC AMINE COMPOUNDS, COMPOSITIONS, AND POLYURETHANE FOAMS MADE THEREFROM DOW GLOBAL TECHNOLOGIES LLC (US) 2013-07-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150005404-A1 CYCLIC AMINE COMPOUNDS, COMPOSITIONS, AND POLYURETHANE FOAMS MADE THEREFROM PUF60, UFM1, POLM CXCR4 2211/4885HSD17B10 1388/4885SIGMAR1 2641/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.